749 A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase IIA clinical trial

✍ Scribed by J. Schneider; W. Halota; D. Delic; Z. Nesic; D. Prokopowicz; R. Flisiak; J. Kuydowicz; M. Jankowski; J. Cianciara; T. Mach; R. Modrzewska; M. Fabri; D. Tomic; A. Horban; W. Krvcka; M. Cripps

• Book ID: 117375025
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 176 KB
• Volume: 44
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(06)80750-6